We are live on ! Find out more
RCKT icon

Rocket Pharmaceuticals
RCKT

119 hedge funds and large institutions have $1.14B invested in Rocket Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 48 increasing their positions, 24 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 24

80% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 15

53% more capital invested

Capital invested by funds: $744M → $1.14B (+$395M)

11% more funds holding

Funds holding: 107 → 119 (+12)

1.48% more ownership

Funds ownership: 96.87% → 98.35% (+1.5%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

Holders
119
Holders Change
+12
Holders Change %
+11.21%
% of All Funds
2.44%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
27
Increased
48
Reduced
24
Closed
15
Calls
$1.28M
Puts
–
Net Calls
+$1.28M
Net Calls Change
+$1.18M

Top Buyers

Rank Fund Capital Flow
1
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
+$17.4M
2
State Street
State Street
Massachusetts
+$11.2M
3
Franklin Resources
Franklin Resources
California
+$9.29M
4
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$8.88M
5
O
OrbiMed
New York
+$6.89M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$29.3M
2
Deutsche Bank
Deutsche Bank
Germany
-$8.87M
3
HM
HealthCor Management
New York
-$5.16M
4
Morgan Stanley
Morgan Stanley
New York
-$4.25M
5
Barclays
Barclays
United Kingdom
-$3.33M
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$9.09M +$416K +23,065 +6%
PI
27
Putnam Investments
Massachusetts
$8.87M +$1.45M +80,637 +24%
Invesco
28
Invesco
Georgia
$8.76M -$2.93M -162,647 -28%
O
29
OrbiMed
New York
$8M +$6.89M +382,400 New
N
30
Nuveen
North Carolina
$7.65M +$1.2M +66,754 +22%
SFM
31
Sphera Funds Management
Israel
$7.12M +$90.1K +5,000 +1%
Dimensional Fund Advisors
32
Dimensional Fund Advisors
Texas
$7.12M +$1.16M +64,422 +23%
TCM
33
Tekla Capital Management
Massachusetts
$6.05M +$1.47M +81,474 +39%
Charles Schwab
34
Charles Schwab
California
$4.86M +$423K +23,454 +11%
D.E. Shaw & Co
35
D.E. Shaw & Co
New York
$4.73M +$339K +18,799 +9%
Axa
36
Axa
France
$4.49M +$198K +10,993 +5%
Millennium Management
37
Millennium Management
New York
$4.29M +$3.7M +204,996 New
VOYA Investment Management
38
VOYA Investment Management
Georgia
$4.1M -$1.43M -79,329 -29%
JP Morgan Chase
39
JP Morgan Chase
New York
$3.62M +$141K +7,802 +5%
LGM
40
Logos Global Management
California
$3.14M +$2.42M +134,191 +849%
SB
41
Samsara BioCapital
California
$2.89M +$180K +10,000 +8%
Bank of New York Mellon
42
Bank of New York Mellon
New York
$2.73M +$131K +7,252 +6%
Allianz Asset Management
43
Allianz Asset Management
Germany
$1.95M +$539K +29,873 +47%
California Public Employees Retirement System
44
California Public Employees Retirement System
California
$1.58M +$137K +7,592 +11%
AA
45
ALPS Advisors
Colorado
$1.57M -$419K -23,245 -24%
Janus Henderson Group
46
Janus Henderson Group
United Kingdom
$1.54M +$101K +5,579 +8%
Swiss National Bank
47
Swiss National Bank
Switzerland
$1.41M +$66.7K +3,700 +6%
Barclays
48
Barclays
United Kingdom
$1.32M -$3.33M -184,668 -75%
MWNA
49
Marshall Wace North America
New York
$1.3M +$1M +55,500 +871%
Macquarie Group
50
Macquarie Group
Australia
$1.24M +$21.2K +1,174 +2%
1
2
3 4 5

RCKT Hedge Fund Activity: Q2 2020 in Review

119 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Rocket Pharmaceuticals (RCKT) for Q2 2020, worth a combined $1.14B — up 53% from $744M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new RCKT positions and 15 closed out — a net gain of 12 holders — while 48 added to existing stakes and 24 trimmed.

The largest buyer was Loomis, Sayles & Company, opening a new position worth an estimated $17.4M. The largest seller was Deerfield Management, cutting an estimated $29.3M.

  • 119 institutional investors held Rocket Pharmaceuticals (RCKT) as of Q2 2020, up from 107 in Q1 2020.
  • Funds reported $1.14B of Rocket Pharmaceuticals stock for Q2 2020, up 53% quarter-over-quarter.
  • 27 funds opened new Rocket Pharmaceuticals positions in Q2 2020 and 15 closed out, a net change of +12 holders.
  • The largest Rocket Pharmaceuticals buyer in Q2 2020 was Loomis, Sayles & Company, an estimated $17.4M added.
  • The largest Rocket Pharmaceuticals seller in Q2 2020 was Deerfield Management, an estimated $29.3M sold.

Based on aggregated 13F filings for Q2 2020.